Recursion Pharmaceuticals, Inc. (RXRX) Earnings Per Share (EPS)
Recursion Pharmaceuticals, Inc. (RXRX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$1.49 |
| 2022-12-31 | -$1.36 |
| 2023-12-31 | -$1.58 |
| 2024-12-31 | -$1.69 |
| 2025-12-31 | -$1.44 |
How RXRX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
| ALEC | Alector Inc. | -$1.39 |
| RLMD | Relmada Therapeutics Inc. | -$1.45 |
| XBIT | XBiotech Inc. | -$1.49 |
| VREX | Varex Imaging Corporation | -$1.70 |
These are five companies in the same sector as RXRX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Recursion Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RXRX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RXRX | $3.16 | -4.53% | 10.46M |
| 3 | ||||
| 4 | ||||
| 5 |